FBIO
Fortress Biotech Inc
2.30$
-4.5%
vs. previous close
Closing price · As of: Sep 23, 2026
Statements
Cash Flow
Fortress Biotech Inc (FBIO) by the numbers: income statement, balance sheet and cash flow, by year or by quarter. In the most recent period (2025), "Operating Cash Flow" came in at -66 million USD. Tick rows to compare them in a chart.
All figures in millions of USD.
Tick rows to compare them in a chart (up to 4)
| Line item | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| -3.5 | -2.4 | -5.7 | -11 | -23 | -30 | -16 | -20 | -46 | -85 | -99 | -95 | -84 | -117 | -179 | -128 | -80 | -66 | |
| – | – | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 | 1.1 | 3.4 | 2.1 | 4.7 | 5.3 | 6.8 | 9.4 | 6.0 | 4.5 | 4.7 | |
| – | – | 2.3 | 1.5 | 3.6 | 5.9 | 5.5 | 14 | 12 | 14 | 15 | 13 | 13 | 19 | 23 | 17 | 33 | 29 | |
| – | – | – | – | 4.7 | – | 6.0 | 15 | 4.7 | -15 | -1.8 | 13 | -43 | 20 | – | – | – | – | |
| -0.3 | 0.2 | 0.3 | 1.8 | -0.4 | 1.1 | -1.5 | 5.2 | 2.0 | -2.2 | 5.7 | -4.8 | -4.8 | 36 | -0.7 | -13 | -8.1 | -25 | |
| 0.0 | 0.0 | 0.0 | 3.8 | 0.3 | 0.2 | 0.0 | 12 | 11 | 5.4 | 9.4 | 9.4 | 7.2 | 16 | 3.1 | 8.1 | 15 | 0.0 | |
| – | 0.0 | 0.0 | -3.8 | -0.3 | -0.2 | -23 | 7.9 | -6.1 | -42 | 19 | 20 | -7.2 | 41 | -23 | -2.1 | -15 | 10 | |
| – | – | – | 0.0 | 17 | 1.9 | 0.0 | 0.3 | 0.3 | 0.3 | 2.3 | 2.6 | 6.8 | 8.8 | 8.8 | 8.8 | 4.7 | 0.7 | |
| – | – | -2.3 | -2.9 | -2.3 | -1.9 | 0.0 | 52 | 0.6 | 1.7 | -0.2 | 0.0 | -0.1 | 24 | -1.2 | -0.4 | 0.0 | -0.3 | |
| – | – | – | – | – | – | -14 | 9.1 | 6.1 | 37 | 0.0 | 15 | -30 | -15 | 49 | -39 | -7.3 | -5.6 | |
| 3.4 | 3.9 | 19 | 23 | 41 | 89 | -10 | 61 | 43 | 150 | 51 | 147 | 172 | 149 | 75 | 33 | 71 | 77 | |
| – | – | 13 | 8.3 | 17 | 59 | -50 | 48 | -9.9 | 27 | -29 | 72 | 82 | 73 | -127 | -98 | -25 | 22 | |
| -3.5 | -2.4 | -5.7 | -15 | -23 | -30 | -16 | -32 | -56 | -91 | -108 | -104 | -91 | -133 | -182 | -136 | -95 | -66 |
Data as of: September 23, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.